| Alexandra Taskier, LMFT | |
|
4924 30th Place Nw, Washington, DC 20008 | |
| (202) 474-3839 | |
| Not Available |
| Full Name | Alexandra Taskier |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 4924 30th Place Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841763471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 166.001258 (Illinois) | Primary |
| 106H00000X | Marriage & Family Therapist | LMFT200001275 (District Of Columbia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Taskier, LMFT 4924 30th Place Nw, Washington, DC 20008 Ph: (202) 474-3839 | Alexandra Taskier, LMFT 4924 30th Place Nw, Washington, DC 20008 Ph: (202) 474-3839 |
News Archive
A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.
Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three and six months ended June 30, 2011.
GenomeDx Biosciences today announced that the robust Decipher genomic analysis platform, successfully classified various subtypes of bladder cancer based on the genomic expression of certain biomarkers, including one type associated with resistance to cisplatin-based chemotherapy. Importantly, this unique genomic signature has potential as a tool to predict tumor responsiveness to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancers (MIBC).
› Verified 1 days ago
Ieisha S Dale, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5225 Connecticut Ave Nw Ste 705, Washington, DC 20015 Phone: 240-863-2618 | |
Dr. Monique Walker, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1320 19th St Nw, Suite 200, Washington, DC 20036 Phone: 202-417-2897 Fax: 202-629-1949 | |
Ms. Melissa P Kester, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1227 Constitution Ave Ne, Washington, DC 20002 Phone: 646-205-7606 | |
Alexandra E Gross, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4455 Connecticut Ave Nw Apt 925, Washington, DC 20008 Phone: 818-457-9489 | |
Dr. Jeanne Bertoli, PHD Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 600 Maryland Ave Sw, Suite 800w, Washington, DC 20024 Phone: 202-580-7492 | |
Danielle Blessing Taylor, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2020 Pennsylvania Ave Nw # 272, Washington, DC 20006 Phone: 202-569-8845 | |
Mrs. Towanda Jackson, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1629 K St Nw, Suite 300, Washington, DC 20006 Phone: 202-809-1174 |